Michael D. Pavy, MD
McLeod Oncology and Hematology Associates
03 SEPTEMBER 2019
In the 1970s, research was undertaken on the drug Tamoxifen as a possible way to help prevent breast cancer in women with a high risk. Results of those studies showed that women, who took the anti-estrogen drug for 5 years experienced a 50% reduction in cancers, compared to those who did not get Tamoxifen. High-risk women include those who had a mother or sister with breast cancer.